Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - HC Wainwright lowered their Q1 2025 earnings per share estimates for Revolution Medicines in a research report issued on Monday, March 3rd. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($1.09.
Publicado el: 2025-03-07 12:03:18
Autor: lulegacy, Fuente: lulegacy